Impact of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia
Description
This study aimed to evaluate the effect of administering nirmatrelvir/ritonavir and molnupiravir prior to hospitalization on subsequent critical illness among patients with coronavirus disease 2019 (COVID-19) pneumonia. This retrospective cohort
